AP
SNY icon

Arlington Partners’s Sanofi SNY Stock Holding History

Arlington Partners’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-325
Closed -$16K – 630
2021
Q4 		$16K Buy
+325
New +$16.1K ﹤0.01% 411
2020
Q2 		– Sell
-109
Closed -$5K – 272
2020
Q1 		$5K Buy
+109
New +$5.21K ﹤0.01% 195

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Arlington Partners's SNY Position: Q1 2022 in Review

Arlington Partners sold out of Sanofi (SNY) in Q1 2022, closing a stake of 325 shares — an estimated $16K sold.

Arlington Partners first reported a position in SNY in Q1 2020 and held it in 2 quarters. The position peaked at $16K in Q4 2021. 623 funds tracked by Wall St. Rank hold SNY as of Q1 2022.

  • Arlington Partners reported no remaining Sanofi position as of Q1 2022 after selling out during the quarter.
  • Arlington Partners sold 325 Sanofi shares in Q1 2022, an estimated $16K.
  • Arlington Partners first reported a position in Sanofi in Q1 2020 and held it in 2 quarters.
  • Arlington Partners's Sanofi position peaked at $16K in Q4 2021.
  • 623 funds tracked by Wall St. Rank held Sanofi as of Q1 2022.

Based on Arlington Partners's 13F filing for Q1 2022, filed 14 Apr 2022.